Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Pancreatic Neoplasms
Interventions
DRUG

QingyiHuaji optimized formula

Qingyihuaji Optimization Formula each bag contains: (1)Scutellaria barbata D. Don (Banzhilian); (2) Hedyotis diffusa Willd. (Sheshecao); (3) Amorphophallus rivieri Durieu (Sheliugu); (4) Amomi Fructus Rotundus (Doukou); (5) Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan); (6) Semen Coicis (Yiyiren); (7) Ganoderma lucidum (Curtis) P. Karst. (Lingzhi). One bag at a time, twice a day, rinsing with boiling water, continuous administration, oral administration in the morning and evening, every 3 weeks as a cycle.

Trial Locations (4)

100000

NOT_YET_RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

200000

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

NOT_YET_RECRUITING

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai

210000

NOT_YET_RECRUITING

Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing

All Listed Sponsors
lead

Fudan University

OTHER